Related references
Note: Only part of the references are listed.A distinct region of the MGMT CpG island critical for transcriptional regulation is preferentially methylated in glioblastoma cells and xenografts
Deborah S. Malley et al.
ACTA NEUROPATHOLOGICA (2011)
Comprehensive Analysis of MGMT Promoter Methylation: Correlation with MGMT Expression and Clinical Response in GBM
Nameeta Shah et al.
PLOS ONE (2011)
Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma
Roger Stupp et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods
Lucie Karayan-Tapon et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
Michael Weller et al.
NATURE REVIEWS NEUROLOGY (2010)
O-6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients
Sabine Spiegl-Kreinecker et al.
NEURO-ONCOLOGY (2010)
O-6-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implications
Alba A. Brandes et al.
NEURO-ONCOLOGY (2010)
Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy
J. Dunn et al.
BRITISH JOURNAL OF CANCER (2009)
Prognostic Impact of O6-Methylguanine-DNA Methyltransferase Silencing in Patients With Recurrent Glioblastoma Multiforme Who Undergo Surgery and Carmustine Wafer Implantation A Prospective Patient Cohort
Philippe Metellus et al.
CANCER (2009)
Prognostic Significance of Molecular Markers and Extent of Resection in Primary Glioblastoma Patients
Joerg Felsberg et al.
CLINICAL CANCER RESEARCH (2009)
Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network
Michael Weller et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas
Sibille Everhard et al.
NEURO-ONCOLOGY (2009)
Prognostic significance of the immunohistochemical expression of O6-methylguanine-DNA methyltransferase, P-glycoprotein, and multidrug resistance protein-1 in glioblastomas
Takao Nakagawa et al.
NEUROPATHOLOGY (2009)
Validation of real-time methylation-specific PCR to determine O6-methylguanine-DNA methyltransferase gene promoter methylation in glioma
Ilse Vlassenbroeck et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2008)
Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach
David Capper et al.
ACTA NEUROPATHOLOGICA (2008)
Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide
Olivier L. Chinot et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation
Tomasz K. Wojdacz et al.
NUCLEIC ACIDS RESEARCH (2007)
O6-Methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas:: Results from the CCG-945 cohort
Ian F. Pollack et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Survival model predictive accuracy and ROC curves
PJ Heagerty et al.
BIOMETRICS (2005)
Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen
M Widschwendter et al.
CANCER RESEARCH (2004)
Relationship between expression of O6-methylguanine-DNA methyltransferase, glutathione-S-transferase, π in glioblastoma and the survival of the patients treated with nimustine hydrochloride:: An immunohistochemical analysis
T Anda et al.
NEUROLOGICAL RESEARCH (2003)
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
M Esteller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
